Purchase Order 75N91020P00699

Award Date 8/15/20
Potential Completion Date 2/14/24
Potential Value $717K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $15,575 purchase order to Illumina, Inc. of San Diego, California for maintenance services. The one-year firm fixed price contract runs from December 5, 2023 through December 4, 2024 to support the agency's research efforts. As the leading federal funder of biomedical research, the NCI utilizes genomic sequencing technologies from Illumina to advance its mission of...
The National Cancer Institute, a component of the Department of Health and Human Services, awarded a $489,805 firm fixed price purchase order to Biofortis, LLC. The contract provides for Biofortis Labmatrix clinical and translational research management software subscriptions, maintenance, and development support services over a base period of performance from August 2021 through August 2022. The original solicitation sought these capabilities on a sole source basis from Biofortis to provide...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a one-year, firm fixed price purchase order valued at fourteen thousand four hundred ninety dollars to Certara USA Inc. for software licenses. Certara will provide the licenses to the NIH NCI in support of its mission to conduct and coordinate research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer,...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,400 firm fixed price purchase order to Thermo Electron North America LLC, doing business as Thermofisher Scientific, for software. The contract has a period of performance through January 21, 2025 with no set-aside designation utilized. Thermofisher Scientific will provide unspecified software to the National Cancer Institute to support its biomedical research mission under this...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $489,800 firm fixed price purchase order to Biofortis, LLC of Potomac, MD. The contract is for Biofortis Labmatrix software and associated maintenance, development support services, and training. This software will provide the National Cancer Institute Center for Cancer Research with a platform to track research information, biospecimens, and results to support the Center's specialized...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $42,551.84 firm fixed price delivery order against the Chief Information Officer Commodities and Solutions (CIO-CS) government-wide acquisition contract to New TECH Solutions, Inc. for software. The delivery order has a period of performance through February 2025 and was awarded on February 15, 2024 without a set aside designation. New TECH Solutions, Inc. will provide the software...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $191,168.97 firm fixed price delivery order to New TECH Solutions, Inc. for software renewal. The contract was awarded under the Chief Information Officer Commodities and Solutions government-wide acquisition contract vehicle, which provides information technology commodities and solutions to federal agencies. New TECH Solutions, Inc. will perform the work as the prime contractor in...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $15,575 purchase order to Illumina, Inc. for maintenance services. The one-year agreement, with performance in Bethesda, Maryland, is for a firm fixed price and covers the period from August 1, 2023 through July 31, 2024. As the prime contractor, Illumina will provide maintenance and support for existing NCI laboratory equipment and technologies. The award was made using...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $41,589.72 delivery order contract to Netcomm, Inc. for software licenses. The contract was awarded against Netcomm's existing Multiple Award Schedule contract vehicle and will provide the licenses to the National Cancer Institute in Bethesda, Maryland through September 2024. As part of its mission to lead the National Cancer Program and conduct and support research, the National Cancer...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $84,817.95 firm fixed price delivery order against the Chief Information Officer Commodities and Solutions government-wide acquisition contract to New TECH Solutions, Inc. for software renewal services. Performance will take place in Fremont, California over a one year period concluding in July 2024. The Chief Information Officer Commodities and Solutions contract vehicle,...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $717,000 firm fixed price purchase order to Flexera Software LLC, doing business as Acresso Software LLC, located in Potomac, Maryland. The award is for the procurement of Flexera software licenses, along with associated customer support and maintenance services, to support the agency's cancer research efforts investigating genetics and epigenetics alterations. The contract period of performance spans from August 15, 2020 through February 14, 2024.

The original solicitation sought preventative maintenance services for an Illumina Next-Seq 550 sequencer to support the Genomics Core's cancer research. The awarded contract with Flexera will provide the software licenses and annual customer support needed to maintain the sequencer and allow for ongoing genetic and epigenetic analysis as part of the National Cancer Institute's research programs.

Generated 12/29/23, 2:42 PM